Why Private Equity Is Furious Over a Paper in a Dermatology Journal

The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
The New York Times
By KATIE HAFNER from NYT Health https://ift.tt/2OTEX4A
October 25, 2018 at 02:00PM